Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

162644596 179525 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179525 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
153585580 179550 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4740491 179550 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585418 179553 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4740519 179553 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
148659040 179670 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(Br)n3c2=O)cc1 nan
CHEMBL4741806 179670 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(Br)n3c2=O)cc1 nan
153585598 179721 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 446 5 1 7 1.9 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4742673 179721 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 446 5 1 7 1.9 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
148397968 179741 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4742901 179741 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
147048009 179763 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(Br)cn3c2=O)cc1 nan
CHEMBL4743199 179763 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(Br)cn3c2=O)cc1 nan
147451915 179793 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4743612 179793 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
152956498 179816 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
CHEMBL4743938 179816 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
153585490 179847 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ncccn2c1=O nan
CHEMBL4744169 179847 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ncccn2c1=O nan
153585688 179864 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4744340 179864 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162647825 179941 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179941 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
152005060 179968 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4745432 179968 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
150944515 179970 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 425 5 2 7 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(NC(=O)OC(C)(C)C)cccn3c2=O)cc1 nan
CHEMBL4745487 179970 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 425 5 2 7 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(NC(=O)OC(C)(C)C)cccn3c2=O)cc1 nan
147626442 179985 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2cn1 nan
CHEMBL4745668 179985 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2cn1 nan
150995037 180025 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4746108 180025 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
162648023 180081 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 2 9 1.5 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4746822 180081 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 2 9 1.5 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585512 180134 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747431 180134 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162650006 180231 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
CHEMBL4748681 180231 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
153585452 180317 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4749705 180317 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)cc1 nan
151976938 180346 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 180346 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
147634500 180384 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 180384 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
149094095 180388 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4750718 180388 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
152023194 180436 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(Cl)cccn3c2=O)cc1 nan
CHEMBL4751203 180436 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(Cl)cccn3c2=O)cc1 nan
153585601 180443 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 478 6 1 8 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4751259 180443 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 478 6 1 8 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585718 180447 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 180447 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585541 180487 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
CHEMBL4751720 180487 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
153585550 180499 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4751886 180499 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
153585655 180582 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
CHEMBL4752993 180582 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
147378727 180633 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4753547 180633 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
162653797 180636 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 180636 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
150050373 180701 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 339 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)nc(C)n3c2=O)cc1 nan
CHEMBL4754384 180701 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 339 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)nc(C)n3c2=O)cc1 nan
149101043 180709 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754476 180709 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585478 180711 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754503 180711 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585445 180863 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4756137 180863 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
153585588 180892 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756392 180892 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585712 180897 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756431 180897 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
94095050 180917 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4756787 180917 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585575 180935 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756937 180935 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
162656575 180989 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4757480 180989 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
153585415 180994 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180994 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
162656504 181002 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4757619 181002 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585404 181014 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4757742 181014 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
149421402 181062 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758375 181062 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657688 181161 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
CHEMBL4759611 181161 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
153585534 181190 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 181190 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
162657416 181226 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4760528 181226 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585663 181261 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
CHEMBL4760812 181261 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
153585574 181327 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 181327 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
162660420 181381 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4762121 181381 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
147987797 181390 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 181390 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
153585643 181447 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4762957 181447 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
147323186 181490 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
CHEMBL4763362 181490 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
153585610 181551 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 181551 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
162661581 181570 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 181570 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
153585681 181589 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764666 181589 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
152494840 181603 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764839 181603 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181875 None 1 Human Functional pEC50 = 9 9.0 3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181875 None 1 Human Functional pEC50 = 9 9.0 3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
162665057 182172 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 182172 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
149618414 182367 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
CHEMBL4783739 182367 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
153585453 182374 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 431 6 1 7 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)F)nccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783815 182374 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 431 6 1 7 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)F)nccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585542 182412 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4784153 182412 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
151570395 182493 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n2c1 nan
CHEMBL4785283 182493 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n2c1 nan
153585417 182533 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
CHEMBL4785963 182533 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
162667558 182568 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4786371 182568 None 0 Human Functional pEC50 = 9 9.0 10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
153585609 182578 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4786573 182578 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151394869 182642 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4787308 182642 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
151043804 182781 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182781 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162670176 182857 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4790080 182857 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
150234341 182896 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4790498 182896 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
149881970 182960 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
CHEMBL4791551 182960 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
149784975 182984 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccncn3c2=O)cc1 nan
CHEMBL4791843 182984 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccncn3c2=O)cc1 nan
162670473 183016 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4792356 183016 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
153585679 183029 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 183029 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162671011 183050 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 183050 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
153585435 183100 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 359 4 1 6 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4793463 183100 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 359 4 1 6 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
153585524 183236 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
CHEMBL4795078 183236 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
153585386 183339 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 183339 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585438 183466 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
CHEMBL4797724 183466 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
153585532 183498 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 183498 None 0 Human Functional pEC50 = 9 9.0 -3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
162675990 183524 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 375 5 1 6 2.0 O=C(Cn1nc2cccnn2c1=O)N[C@H](c1ccc(Cl)c(F)c1)C1CC1 nan
CHEMBL4798509 183524 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 375 5 1 6 2.0 O=C(Cn1nc2cccnn2c1=O)N[C@H](c1ccc(Cl)c(F)c1)C1CC1 nan
153585488 183573 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4799144 183573 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585707 183684 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4800487 183684 None 0 Human Functional pEC50 = 9 9.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
153585650 179510 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4740004 179510 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162644596 179525 None 0 Human Functional pEC50 = 8 8.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179525 None 0 Human Functional pEC50 = 8 8.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648528 179920 None 0 Human Functional pEC50 = 8 8.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
CHEMBL4744984 179920 None 0 Human Functional pEC50 = 8 8.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
146867363 179982 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 7 1 8 2.0 C[C@H](NC(=O)Cn1nc2cc(OC3CN(C)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4745642 179982 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 7 1 8 2.0 C[C@H](NC(=O)Cn1nc2cc(OC3CN(C)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162649809 180151 None 0 Human Functional pEC50 = 8 8.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 180151 None 0 Human Functional pEC50 = 8 8.0 1 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585543 180342 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1 nan
CHEMBL4750043 180342 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1 nan
153585514 180479 None 0 Human Functional pEC50 = 8 8.0 -10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
CHEMBL4751629 180479 None 0 Human Functional pEC50 = 8 8.0 -10 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
153585659 180738 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 6 1 7 1.5 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4754933 180738 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 6 1 7 1.5 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
153585592 180849 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 2 8 1.7 C[C@H](NC(=O)Cn1nc2cccc(N3CCNCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4755986 180849 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 2 8 1.7 C[C@H](NC(=O)Cn1nc2cccc(N3CCNCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
133916051 181355 None 1 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 356 5 1 5 2.4 O=C(Cn1nc2ccccn2c1=O)NC(c1ccc(Cl)cc1)C1CC1 nan
CHEMBL4761733 181355 None 1 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 356 5 1 5 2.4 O=C(Cn1nc2ccccn2c1=O)NC(c1ccc(Cl)cc1)C1CC1 nan
153065968 181384 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 354 6 1 6 2.2 CC(C)Oc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4762154 181384 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 354 6 1 6 2.2 CC(C)Oc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
153585680 181392 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(F)cc1 nan
CHEMBL4762210 181392 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(F)cc1 nan
151392727 181829 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 1 8 2.7 C[C@H](NC(=O)Cn1nc2ccc(N3CCCCC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4777046 181829 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 1 8 2.7 C[C@H](NC(=O)Cn1nc2ccc(N3CCCCC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181875 None 1 Human Functional pEC50 = 8 8.0 3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181875 None 1 Human Functional pEC50 = 8 8.0 3 2
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
153585533 182157 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 372 5 1 5 3.0 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(-c2ccccc2)cc1 nan
CHEMBL4781160 182157 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 372 5 1 5 3.0 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(-c2ccccc2)cc1 nan
153585698 182527 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4785855 182527 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)cc1 nan
149374815 182607 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnccn3c2=O)cc1 nan
CHEMBL4786952 182607 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnccn3c2=O)cc1 nan
153585657 182676 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 4 1 5 2.1 O=C(Cn1nc2ccc(F)cn2c1=O)NC1(c2ccc(Cl)cc2)CC1 nan
CHEMBL4787820 182676 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 4 1 5 2.1 O=C(Cn1nc2ccc(F)cn2c1=O)NC1(c2ccc(Cl)cc2)CC1 nan
121349628 182131 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
121349628 182131 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
CHEMBL4780801 182131 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4780801 182131 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
121349739 182276 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4782619 182276 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
121349631 182588 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4786722 182588 None 0 Human Functional pEC50 = 8 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
122195502 124184 None 0 Human Functional pEC50 = 5 5.0 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 402 8 2 3 3.9 COc1cccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633717 124184 None 0 Human Functional pEC50 = 5 5.0 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 402 8 2 3 3.9 COc1cccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
169098787 195354 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 359 5 1 5 3.1 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5401884 195354 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 359 5 1 5 3.1 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
121349564 181870 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349564 181870 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4777630 181870 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4777630 181870 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349633 182823 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4789631 182823 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
164628435 186396 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4874254 186396 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
169098787 195354 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 359 5 1 5 3.1 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5401884 195354 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 359 5 1 5 3.1 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
169098812 195915 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 296 4 1 5 1.4 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5413318 195915 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 296 4 1 5 1.4 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
169098812 195915 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 296 4 1 5 1.4 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5413318 195915 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 296 4 1 5 1.4 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
26532940 124187 None 1 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633721 124187 None 1 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
164621186 186200 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871591 186200 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
169098828 195619 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 4 1 5 1.7 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccccc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5407185 195619 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 4 1 5 1.7 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccccc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
169098828 195619 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 4 1 5 1.7 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccccc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5407185 195619 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 4 1 5 1.7 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccccc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
121349572 181952 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4778561 181952 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349566 182758 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4788831 182758 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
121349806 183480 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4797857 183480 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
169098802 196973 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.3c01034
CHEMBL5435834 196973 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.3c01034
169098802 196973 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.3c01034
CHEMBL5435834 196973 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.3c01034
2114212 20937 None 11 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 5 1 5 1.2 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL1310918 20937 None 11 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 5 1 5 1.2 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1 10.1021/acs.jmedchem.1c00820
121349764 182994 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 360 4 1 5 2.5 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Cl nan
CHEMBL4792090 182994 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 360 4 1 5 2.5 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Cl nan
36428174 182048 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4779855 182048 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349734 182202 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
CHEMBL4781729 182202 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
121349683 182829 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4789720 182829 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
121349710 183054 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4792828 183054 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349767 183436 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797410 183436 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
2303171 124186 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633719 124186 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349643 183552 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 4 1 5 2.6 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Br nan
CHEMBL4798899 183552 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 4 1 5 2.6 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Br nan
170222195 196983 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 406 5 1 5 3.3 Cc1ccc2cnn(CC(=O)N[C@H](c3ccc(C(F)(F)F)cc3)C(C)C)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5436077 196983 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 406 5 1 5 3.3 Cc1ccc2cnn(CC(=O)N[C@H](c3ccc(C(F)(F)F)cc3)C(C)C)c(=O)n12 10.1021/acs.jmedchem.3c01034
164611430 185330 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
CHEMBL4857947 185330 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
121349781 181954 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4778563 181954 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349675 182071 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4780038 182071 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349763 182574 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@@H](C)n1nnc2ccccc2c1=O nan
CHEMBL4786501 182574 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@@H](C)n1nnc2ccccc2c1=O nan
121349809 183267 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4795372 183267 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349689 183325 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4796061 183325 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
2548547 2149 None 39 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
8766 2149 None 39 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
CHEMBL3633720 2149 None 39 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
170222195 196983 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 406 5 1 5 3.3 Cc1ccc2cnn(CC(=O)N[C@H](c3ccc(C(F)(F)F)cc3)C(C)C)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5436077 196983 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 406 5 1 5 3.3 Cc1ccc2cnn(CC(=O)N[C@H](c3ccc(C(F)(F)F)cc3)C(C)C)c(=O)n12 10.1021/acs.jmedchem.3c01034
1555702 124185 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 282 5 2 2 2.3 C[C@H](NC(=O)CNC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633718 124185 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 282 5 2 2 2.3 C[C@H](NC(=O)CNC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349597 181917 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
CHEMBL4778124 181917 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
121349786 182359 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
CHEMBL4783626 182359 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
170196135 195762 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 327 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2ncc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5410300 195762 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 327 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2ncc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
28918448 124206 None 2 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633895 124206 None 2 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349574 182925 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349574 182925 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4790968 182925 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4790968 182925 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
121349782 183150 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4794046 183150 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
169098807 197094 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 388 4 1 5 2.4 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(Br)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5438556 197094 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 388 4 1 5 2.4 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(Br)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
170222108 196158 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 328 4 1 5 1.8 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5417840 196158 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 328 4 1 5 1.8 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
170196135 195762 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 327 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2ncc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5410300 195762 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 327 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2ncc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
121349740 182197 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4781651 182197 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349745 182318 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
121349745 182318 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
CHEMBL4783071 182318 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4783071 182318 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
121349593 182979 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4791792 182979 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
169098813 196821 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 4 1 5 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccccc3)ncc12 10.1021/acs.jmedchem.3c01034
CHEMBL5432850 196821 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 4 1 5 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccccc3)ncc12 10.1021/acs.jmedchem.3c01034
170222108 196158 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 328 4 1 5 1.8 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5417840 196158 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 328 4 1 5 1.8 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
169098813 196821 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 4 1 5 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccccc3)ncc12 10.1021/acs.jmedchem.3c01034
CHEMBL5432850 196821 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 4 1 5 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccccc3)ncc12 10.1021/acs.jmedchem.3c01034
169098809 194976 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2ncc3ccc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5394347 194976 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2ncc3ccc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098807 197094 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 388 4 1 5 2.4 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(Br)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5438556 197094 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 388 4 1 5 2.4 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(Br)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
40719079 124198 None 1 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633885 124198 None 1 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349656 183595 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4799483 183595 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
169098809 194976 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2ncc3ccc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5394347 194976 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2ncc3ccc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098781 195441 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 391 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5403952 195441 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 391 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.3c01034
169098781 195441 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 391 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5403952 195441 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 391 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.3c01034
121349786 182359 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4783626 182359 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349593 182979 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
CHEMBL4791792 182979 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
2695546 186222 None 9 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871792 186222 None 9 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
169098810 195809 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 5 1 5 2.1 CC[C@H](NC(=O)Cn1ncc2ccc(C)n2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5411110 195809 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 5 1 5 2.1 CC[C@H](NC(=O)Cn1ncc2ccc(C)n2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
169098800 196140 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 328 4 1 6 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5417548 196140 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 328 4 1 6 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098810 195809 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 5 1 5 2.1 CC[C@H](NC(=O)Cn1ncc2ccc(C)n2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5411110 195809 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 5 1 5 2.1 CC[C@H](NC(=O)Cn1ncc2ccc(C)n2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
169098782 195002 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 348 4 1 6 2.4 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5394715 195002 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 348 4 1 6 2.4 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
169098837 197102 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 344 4 1 5 2.3 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5438741 197102 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 344 4 1 5 2.3 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
2548543 124207 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633896 124207 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
11685 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
11685 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349608 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
121349608 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
CHEMBL4779773 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
CHEMBL4779773 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
2714485 183048 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 326 4 1 5 1.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1 nan
CHEMBL4792727 183048 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 326 4 1 5 1.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1 nan
121349719 183365 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349719 183365 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4796493 183365 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4796493 183365 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
8036946 183545 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798779 183545 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
169098800 196140 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 328 4 1 6 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5417548 196140 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 328 4 1 6 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098784 196845 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 365 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1Cl 10.1021/acs.jmedchem.3c01034
CHEMBL5433281 196845 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 365 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1Cl 10.1021/acs.jmedchem.3c01034
169098782 195002 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 348 4 1 6 2.4 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5394715 195002 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 348 4 1 6 2.4 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
169098837 197102 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 344 4 1 5 2.3 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5438741 197102 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 344 4 1 5 2.3 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
169098785 195709 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 347 4 1 5 3.0 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5409401 195709 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 347 4 1 5 3.0 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
16132144 211738 None 29 Human Functional pEC50 = 5.7 5.7 -3388 8
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by Fluo-4 calcium assayAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by Fluo-4 calcium assay
ChEMBL None None None CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C 10.1021/acs.jmedchem.3c01034
16133793 211738 None 29 Human Functional pEC50 = 5.7 5.7 -3388 8
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by Fluo-4 calcium assayAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by Fluo-4 calcium assay
ChEMBL None None None CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C 10.1021/acs.jmedchem.3c01034
44273719 211738 None 29 Human Functional pEC50 = 5.7 5.7 -3388 8
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by Fluo-4 calcium assayAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by Fluo-4 calcium assay
ChEMBL None None None CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C 10.1021/acs.jmedchem.3c01034
CHEMBL214332 211738 None 29 Human Functional pEC50 = 5.7 5.7 -3388 8
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by Fluo-4 calcium assayAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by Fluo-4 calcium assay
ChEMBL None None None CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C 10.1021/acs.jmedchem.3c01034
169098784 196845 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 365 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1Cl 10.1021/acs.jmedchem.3c01034
CHEMBL5433281 196845 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 365 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1Cl 10.1021/acs.jmedchem.3c01034
170222155 196793 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 340 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2ncc3ccc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5432364 196793 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 340 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2ncc3ccc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
121349614 181771 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
CHEMBL4776329 181771 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
27783537 181789 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 nan
CHEMBL4776509 181789 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 nan
121349728 181922 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349728 181922 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
CHEMBL4778172 181922 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4778172 181922 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
41757362 182319 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4783081 182319 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349658 182809 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4789475 182809 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
27785340 183577 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4799237 183577 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
27754276 186037 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869182 186037 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
7534868 124191 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 296 5 2 2 2.6 Cc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633878 124191 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 296 5 2 2 2.6 Cc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
122195644 124201 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 334 5 2 2 3.1 C[C@H](NC(=O)CNC(=O)c1cc(F)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633888 124201 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 334 5 2 2 3.1 C[C@H](NC(=O)CNC(=O)c1cc(F)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
169098785 195709 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 347 4 1 5 3.0 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5409401 195709 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 347 4 1 5 3.0 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
170222155 196793 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 340 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2ncc3ccc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5432364 196793 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 340 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2ncc3ccc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098799 196535 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 349 4 1 5 2.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)c(F)c1 10.1021/acs.jmedchem.3c01034
CHEMBL5426183 196535 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 349 4 1 5 2.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)c(F)c1 10.1021/acs.jmedchem.3c01034
121349701 182050 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
CHEMBL4779884 182050 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
169098799 196535 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 349 4 1 5 2.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)c(F)c1 10.1021/acs.jmedchem.3c01034
CHEMBL5426183 196535 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 349 4 1 5 2.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)c(F)c1 10.1021/acs.jmedchem.3c01034
121349805 183226 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
CHEMBL4794908 183226 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
170196143 195887 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 338 4 1 6 2.2 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C#N)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5412645 195887 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 338 4 1 6 2.2 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C#N)cc1 10.1021/acs.jmedchem.3c01034
121349755 181909 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4778062 181909 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349734 182202 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4781729 182202 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
27785340 183577 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4799237 183577 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
172442141 195224 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 363 4 1 5 3.5 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.3c01034
CHEMBL5399140 195224 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 363 4 1 5 3.5 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.3c01034
169098829 195398 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2ncc3cccn3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5402898 195398 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2ncc3cccn3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098789 196290 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 349 4 1 5 2.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1F 10.1021/acs.jmedchem.3c01034
CHEMBL5420577 196290 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 349 4 1 5 2.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1F 10.1021/acs.jmedchem.3c01034
170222160 196341 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 346 4 1 5 2.5 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.3c01034
CHEMBL5421824 196341 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 346 4 1 5 2.5 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.3c01034
170196143 195887 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 338 4 1 6 2.2 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C#N)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5412645 195887 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 338 4 1 6 2.2 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C#N)cc1 10.1021/acs.jmedchem.3c01034
169098789 196290 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 349 4 1 5 2.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1F 10.1021/acs.jmedchem.3c01034
CHEMBL5420577 196290 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 349 4 1 5 2.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1F 10.1021/acs.jmedchem.3c01034
169098806 195162 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 330 4 1 5 2.0 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5397779 195162 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 330 4 1 5 2.0 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
169098801 195589 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.4 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5406603 195589 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.4 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
169098829 195398 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2ncc3cccn3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5402898 195398 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2ncc3cccn3c2=O)cc1 10.1021/acs.jmedchem.3c01034
172442141 195224 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 363 4 1 5 3.5 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.3c01034
CHEMBL5399140 195224 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 363 4 1 5 3.5 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.3c01034
169098801 195589 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.4 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5406603 195589 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.4 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
122195501 124183 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 3 4 1.7 COc1cccc(C(=O)N[C@@H](CO)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633716 124183 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 3 4 1.7 COc1cccc(C(=O)N[C@@H](CO)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
8036887 184846 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4850747 184846 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349639 182523 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349639 182523 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4785741 182523 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4785741 182523 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
170222160 196341 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 346 4 1 5 2.5 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.3c01034
CHEMBL5421824 196341 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 346 4 1 5 2.5 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.3c01034
169098806 195162 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 330 4 1 5 2.0 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5397779 195162 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 330 4 1 5 2.0 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.3c01034
3341369 47659 None 5 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 328 4 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1546963 47659 None 5 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 328 4 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349694 182321 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
121349694 182321 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
CHEMBL4783106 182321 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
CHEMBL4783106 182321 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
121349596 183547 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798863 183547 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
164609046 184591 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847108 184591 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349780 186475 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4875522 186475 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
169098834 196189 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 356 5 1 5 2.5 Cc1ccc2cnn(CC(=O)N[C@H](c3ccc(F)cc3)C(C)C)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5418368 196189 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 356 5 1 5 2.5 Cc1ccc2cnn(CC(=O)N[C@H](c3ccc(F)cc3)C(C)C)c(=O)n12 10.1021/acs.jmedchem.3c01034
121349738 182203 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4781754 182203 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
169098834 196189 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 356 5 1 5 2.5 Cc1ccc2cnn(CC(=O)N[C@H](c3ccc(F)cc3)C(C)C)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5418368 196189 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 356 5 1 5 2.5 Cc1ccc2cnn(CC(=O)N[C@H](c3ccc(F)cc3)C(C)C)c(=O)n12 10.1021/acs.jmedchem.3c01034
170222162 196320 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 374 4 1 5 2.1 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5421380 196320 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 374 4 1 5 2.1 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.3c01034
170222162 196320 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 374 4 1 5 2.1 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5421380 196320 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 374 4 1 5 2.1 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.3c01034
121349572 181952 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4778561 181952 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
2109722 124203 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 2 4 2.3 COc1cc(OC)cc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633890 124203 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 2 4 2.3 COc1cc(OC)cc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
170196141 196224 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 314 4 1 6 1.7 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccn1 10.1021/acs.jmedchem.3c01034
CHEMBL5419310 196224 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 314 4 1 6 1.7 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccn1 10.1021/acs.jmedchem.3c01034
121349658 182809 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
CHEMBL4789475 182809 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
121349548 183535 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798667 183535 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
8036946 183545 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4798779 183545 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
26810968 186389 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
CHEMBL4874147 186389 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
28918445 124194 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633881 124194 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
169098838 195403 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 354 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2ncc3c(C)cc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5403066 195403 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 354 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2ncc3c(C)cc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
170196141 196224 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 314 4 1 6 1.7 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccn1 10.1021/acs.jmedchem.3c01034
CHEMBL5419310 196224 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 314 4 1 6 1.7 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccn1 10.1021/acs.jmedchem.3c01034
169098838 195403 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 354 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2ncc3c(C)cc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5403066 195403 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 354 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2ncc3c(C)cc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
172470545 197063 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)cc1Cl 10.1021/acs.jmedchem.3c01034
CHEMBL5437907 197063 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)cc1Cl 10.1021/acs.jmedchem.3c01034
172470545 197063 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)cc1Cl 10.1021/acs.jmedchem.3c01034
CHEMBL5437907 197063 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 381 4 1 5 3.6 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)cc1Cl 10.1021/acs.jmedchem.3c01034
121349633 182823 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4789631 182823 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
121349767 183436 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
CHEMBL4797410 183436 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
121349559 181942 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
CHEMBL4778354 181942 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
121349615 183231 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4795005 183231 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349746 183490 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797979 183490 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349645 181824 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4776988 181824 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349720 182349 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
CHEMBL4783544 182349 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
122195642 124199 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633886 124199 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349688 183004 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4792174 183004 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
169098788 196753 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 331 4 1 5 2.5 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5431491 196753 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 331 4 1 5 2.5 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
121349659 182371 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4783774 182371 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
169098788 196753 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 331 4 1 5 2.5 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5431491 196753 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 331 4 1 5 2.5 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
121349600 182691 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4788013 182691 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
3376937 124204 None 45 Human Functional pEC50 = 7.4 7.4 70 2
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 365 4 3 4 3.3 COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633893 124204 None 45 Human Functional pEC50 = 7.4 7.4 70 2
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 365 4 3 4 3.3 COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1 10.1021/acsmedchemlett.5b00247
170222165 195018 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 360 4 1 5 2.8 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3cccc4ccccc34)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5395065 195018 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 360 4 1 5 2.8 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3cccc4ccccc34)c(=O)n12 10.1021/acs.jmedchem.3c01034
122195500 124182 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633715 124182 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349746 183490 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4797979 183490 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
170222165 195018 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 360 4 1 5 2.8 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3cccc4ccccc34)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5395065 195018 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 360 4 1 5 2.8 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3cccc4ccccc34)c(=O)n12 10.1021/acs.jmedchem.3c01034
2496250 28960 None 4 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1380104 28960 None 4 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
122195640 124196 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 366 6 2 3 3.2 C[C@H](NC(=O)CNC(=O)c1cccc(OC(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633883 124196 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 366 6 2 3 3.2 C[C@H](NC(=O)CNC(=O)c1cccc(OC(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
122195643 124200 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633887 124200 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
169098803 196866 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 344 5 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5433669 196866 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 344 5 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
170196155 197082 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 398 5 1 7 2.6 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(OC(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5438241 197082 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 398 5 1 7 2.6 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(OC(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
169098803 196866 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 344 5 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5433669 196866 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 344 5 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098815 196204 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 5 1 5 1.8 CC[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5418797 196204 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 5 1 5 1.8 CC[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
121349558 182078 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4780121 182078 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
121349685 182239 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4782204 182239 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
169098815 196204 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 5 1 5 1.8 CC[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5418797 196204 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 310 5 1 5 1.8 CC[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
121349623 182206 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
CHEMBL4781805 182206 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
121349588 182342 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783365 182342 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
170196155 197082 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 398 5 1 7 2.6 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(OC(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5438241 197082 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 398 5 1 7 2.6 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(OC(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
121349773 182534 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
CHEMBL4785980 182534 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
169098791 194967 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 343 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2ncc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5394251 194967 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 343 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2ncc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
121349793 181929 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@H](C)n1nnc2ccccc2c1=O nan
CHEMBL4778263 181929 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@H](C)n1nnc2ccccc2c1=O nan
122195639 124195 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.3 C[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633882 124195 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.3 C[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
122195641 124197 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633884 124197 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
169098798 196930 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 327 5 1 5 2.7 CC[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5435044 196930 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 327 5 1 5 2.7 CC[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
169098791 194967 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 343 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2ncc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5394251 194967 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 343 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2ncc3sccc3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098798 196930 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 327 5 1 5 2.7 CC[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5435044 196930 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 327 5 1 5 2.7 CC[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
169098820 194993 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 358 4 1 5 2.6 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)ncc12 10.1021/acs.jmedchem.3c01034
CHEMBL5394567 194993 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 358 4 1 5 2.6 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)ncc12 10.1021/acs.jmedchem.3c01034
2714528 182584 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
CHEMBL4786641 182584 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
2714527 185511 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4861019 185511 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349679 186374 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4873905 186374 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
28821961 124193 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 300 5 2 2 2.4 C[C@H](NC(=O)CNC(=O)c1cccc(F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633880 124193 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 300 5 2 2 2.4 C[C@H](NC(=O)CNC(=O)c1cccc(F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
169098779 195654 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 313 4 1 5 2.3 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5408151 195654 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 313 4 1 5 2.3 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
170222105 195139 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5397321 195139 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
169098779 195654 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 313 4 1 5 2.3 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5408151 195654 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 313 4 1 5 2.3 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
169098811 196618 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5427962 196618 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
169098820 194993 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 358 4 1 5 2.6 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)ncc12 10.1021/acs.jmedchem.3c01034
CHEMBL5394567 194993 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 358 4 1 5 2.6 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)ncc12 10.1021/acs.jmedchem.3c01034
169098811 196618 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5427962 196618 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
169098818 196662 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 378 4 1 5 2.7 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5429215 196662 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 378 4 1 5 2.7 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
169098792 196964 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 332 4 1 6 1.9 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5435655 196964 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 332 4 1 6 1.9 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
170222105 195139 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5397321 195139 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
169098792 196964 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 332 4 1 6 1.9 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5435655 196964 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 332 4 1 6 1.9 C[C@H](NC(=O)Cn1nnc2sccc2c1=O)c1ccc(F)cc1 10.1021/acs.jmedchem.3c01034
121349685 182239 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4782204 182239 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
169098818 196662 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 378 4 1 5 2.7 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5429215 196662 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 378 4 1 5 2.7 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
169098823 196111 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 326 5 1 6 1.4 COc1ccc([C@H](C)NC(=O)Cn2ncc3cccn3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5417091 196111 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 326 5 1 6 1.4 COc1ccc([C@H](C)NC(=O)Cn2ncc3cccn3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098835 196233 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 5 1 5 2.0 CC(C)[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5419423 196233 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 5 1 5 2.0 CC(C)[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
122195638 124192 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 307 5 2 3 2.2 C[C@H](NC(=O)CNC(=O)c1cccc(C#N)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633879 124192 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 307 5 2 3 2.2 C[C@H](NC(=O)CNC(=O)c1cccc(C#N)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
169098823 196111 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 326 5 1 6 1.4 COc1ccc([C@H](C)NC(=O)Cn2ncc3cccn3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5417091 196111 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 326 5 1 6 1.4 COc1ccc([C@H](C)NC(=O)Cn2ncc3cccn3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098835 196233 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 5 1 5 2.0 CC(C)[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5419423 196233 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 324 5 1 5 2.0 CC(C)[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
121349795 183555 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4798933 183555 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
27838947 185537 None 1 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4861445 185537 None 1 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
2998350 38115 None 4 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 334 3 1 5 2.0 O=C(Cn1nnc2ccccc2c1=O)NC1CCCc2ccccc21 10.1021/acs.jmedchem.1c00820
CHEMBL1460960 38115 None 4 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 334 3 1 5 2.0 O=C(Cn1nnc2ccccc2c1=O)NC1CCCc2ccccc21 10.1021/acs.jmedchem.1c00820
122195499 124181 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633714 124181 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
41757362 182319 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4783081 182319 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349753 183000 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
CHEMBL4792136 183000 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
2856847 124205 None 7 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 299 5 1 3 3.4 CC(NC(=O)CSC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633894 124205 None 7 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 299 5 1 3 3.4 CC(NC(=O)CSC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
164619649 185872 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
CHEMBL4866435 185872 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
169098797 195084 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 341 5 1 5 3.0 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5396468 195084 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 341 5 1 5 3.0 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
169098797 195084 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 341 5 1 5 3.0 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
CHEMBL5396468 195084 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 341 5 1 5 3.0 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.3c01034
121349671 181859 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4777495 181859 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349778 182462 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4784744 182462 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349756 182673 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4787761 182673 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
121349555 182743 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4788631 182743 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349787 182778 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4789079 182778 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349554 183645 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
CHEMBL4800089 183645 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
164617704 184637 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 7 1.4 COc1ccc([C@H](C)NS(=O)(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847795 184637 None 0 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 7 1.4 COc1ccc([C@H](C)NS(=O)(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
170196145 195721 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 409 5 1 5 4.0 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5409522 195721 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 409 5 1 5 4.0 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
169098819 195048 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 394 5 1 6 2.6 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5395516 195048 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 394 5 1 6 2.6 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
169098819 195048 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 394 5 1 6 2.6 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
CHEMBL5395516 195048 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 394 5 1 6 2.6 Cc1ccc2cnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 10.1021/acs.jmedchem.3c01034
164617980 185135 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
CHEMBL4855076 185135 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
170196145 195721 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 409 5 1 5 4.0 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5409522 195721 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 409 5 1 5 4.0 CC(C)[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
122195645 124202 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 394 5 2 2 3.7 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Br)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633889 124202 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 394 5 2 2 3.7 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Br)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
78596259 185481 None 1 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4860510 185481 None 1 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349587 182518 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4785669 182518 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
169098783 195342 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 365 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)c(F)c1 10.1021/acs.jmedchem.3c01034
CHEMBL5401670 195342 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 365 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)c(F)c1 10.1021/acs.jmedchem.3c01034
169098783 195342 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 365 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)c(F)c1 10.1021/acs.jmedchem.3c01034
CHEMBL5401670 195342 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 365 4 1 5 3.1 C[C@H](NC(=O)Cn1ncc2sccc2c1=O)c1ccc(Cl)c(F)c1 10.1021/acs.jmedchem.3c01034
170222172 196314 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 392 5 1 5 3.0 CC(C)[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5421234 196314 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 392 5 1 5 3.0 CC(C)[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
170222172 196314 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 392 5 1 5 3.0 CC(C)[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5421234 196314 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 392 5 1 5 3.0 CC(C)[C@H](NC(=O)Cn1ncc2cccn2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.3c01034
164620660 186051 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 384 6 1 5 2.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(-c2ccccc2)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869485 186051 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 384 6 1 5 2.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(-c2ccccc2)cc1 10.1021/acs.jmedchem.1c00820
169098832 195239 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 338 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2ncc3c(C)cc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5399292 195239 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 338 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2ncc3c(C)cc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
27783537 181789 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4776509 181789 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
121349569 182021 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4779481 182021 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349561 182836 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4789791 182836 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349769 183033 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4792561 183033 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349596 183547 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798863 183547 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
164620725 186191 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871506 186191 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
36428174 182048 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4779855 182048 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349753 183000 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4792136 183000 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
169098832 195239 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 338 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2ncc3c(C)cc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
CHEMBL5399292 195239 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 338 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2ncc3c(C)cc(C)n3c2=O)cc1 10.1021/acs.jmedchem.3c01034
169098816 195493 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 408 5 1 6 2.9 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)ncc12 10.1021/acs.jmedchem.3c01034
CHEMBL5404791 195493 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 408 5 1 6 2.9 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)ncc12 10.1021/acs.jmedchem.3c01034
169098817 195837 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 342 4 1 5 2.1 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(F)cc3)ncc12 10.1021/acs.jmedchem.3c01034
CHEMBL5411677 195837 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 342 4 1 5 2.1 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(F)cc3)ncc12 10.1021/acs.jmedchem.3c01034
169098817 195837 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 342 4 1 5 2.1 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(F)cc3)ncc12 10.1021/acs.jmedchem.3c01034
CHEMBL5411677 195837 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 342 4 1 5 2.1 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(F)cc3)ncc12 10.1021/acs.jmedchem.3c01034
169098816 195493 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 408 5 1 6 2.9 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)ncc12 10.1021/acs.jmedchem.3c01034
CHEMBL5404791 195493 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysisAgonist activity at human GPR139 transfected in CHO-K1 cells assessed as increase in calcium mobilization by FLIPR analysis
ChEMBL 408 5 1 6 2.9 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)ncc12 10.1021/acs.jmedchem.3c01034
11685 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
121349608 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
CHEMBL4779773 4139 None 28 Human Functional pEC50 = 7.7 7.7 - 1
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
2144 2356 None 0 Human Functional pEC50 = 3.5 3.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
3313 2356 None 0 Human Functional pEC50 = 3.5 3.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
6140 2356 None 0 Human Functional pEC50 = 3.5 3.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
6925665 2356 None 0 Human Functional pEC50 = 3.5 3.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
CHEMBL301523 2356 None 0 Human Functional pEC50 = 3.5 3.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
DB00120 2356 None 0 Human Functional pEC50 = 3.5 3.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
2780 2373 None 60 Human Functional pEC50 = 3.7 3.7 13 2
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
6305 2373 None 60 Human Functional pEC50 = 3.7 3.7 13 2
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
6923516 2373 None 60 Human Functional pEC50 = 3.7 3.7 13 2
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
717 2373 None 60 Human Functional pEC50 = 3.7 3.7 13 2
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
CHEMBL54976 2373 None 60 Human Functional pEC50 = 3.7 3.7 13 2
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
DB00150 2373 None 60 Human Functional pEC50 = 3.7 3.7 13 2
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
7799 1011 None 0 Human Functional pEC50 = 7.4 7.4 - 1
UnclassifiedUnclassified
Guide to Pharmacology 365 4 3 4 3.3 COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2 24900311
86277840 1011 None 0 Human Functional pEC50 = 7.4 7.4 - 1
UnclassifiedUnclassified
Guide to Pharmacology 365 4 3 4 3.3 COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2 24900311
2144 2356 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
3313 2356 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
6140 2356 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
6925665 2356 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
CHEMBL301523 2356 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
DB00120 2356 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
2780 2373 None 60 Human Functional pIC50 = 8.3 8.3 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
6305 2373 None 60 Human Functional pIC50 = 8.3 8.3 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
6923516 2373 None 60 Human Functional pIC50 = 8.3 8.3 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
717 2373 None 60 Human Functional pIC50 = 8.3 8.3 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
CHEMBL54976 2373 None 60 Human Functional pIC50 = 8.3 8.3 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
DB00150 2373 None 60 Human Functional pIC50 = 8.3 8.3 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
12363 2751 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Inhibition of Ca<sup>2+</sup> mobilizationInhibition of Ca<sup>2+</sup> mobilization
Guide to Pharmacology 340 1 1 3 4.8 Oc1cc2c(cc1)c(=O)c(c1ccc(Cl)cc1)c(o2)C(F)(F)F 36736525
5348723 2751 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Inhibition of Ca<sup>2+</sup> mobilizationInhibition of Ca<sup>2+</sup> mobilization
Guide to Pharmacology 340 1 1 3 4.8 Oc1cc2c(cc1)c(=O)c(c1ccc(Cl)cc1)c(o2)C(F)(F)F 36736525
2144 2356 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
3313 2356 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6140 2356 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6925665 2356 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
CHEMBL301523 2356 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
DB00120 2356 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
2780 2373 None 60 Human Functional pIC50 = 4.6 4.6 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6305 2373 None 60 Human Functional pIC50 = 4.6 4.6 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6923516 2373 None 60 Human Functional pIC50 = 4.6 4.6 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
717 2373 None 60 Human Functional pIC50 = 4.6 4.6 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
CHEMBL54976 2373 None 60 Human Functional pIC50 = 4.6 4.6 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
DB00150 2373 None 60 Human Functional pIC50 = 4.6 4.6 13 2
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
789353 2354 None 0 Human Functional pIC50 = 6.2 6.2 - 1
UnclassifiedUnclassified
Guide to Pharmacology 329 4 1 2 4.8 Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1 19525486
8774 2354 None 0 Human Functional pIC50 = 6.2 6.2 - 1
UnclassifiedUnclassified
Guide to Pharmacology 329 4 1 2 4.8 Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1 19525486
5017692 2750 None 0 Human Functional pIC50 = 6.7 6.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 289 3 0 2 3.4 COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F 26027661
8775 2750 None 0 Human Functional pIC50 = 6.7 6.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 289 3 0 2 3.4 COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F 26027661




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

153585580 179550 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4740491 179550 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
148397968 179741 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4742901 179741 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
153585666 179743 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 1 6 2.2 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4742949 179743 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 1 6 2.2 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
147451915 179793 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4743612 179793 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585625 179799 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)ccn3c2=O)cc1 nan
CHEMBL4743662 179799 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)ccn3c2=O)cc1 nan
153585420 179916 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4744927 179916 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
153585722 180053 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4746401 180053 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
162649907 180189 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 2 7 1.6 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4748076 180189 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 2 7 1.6 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
152844759 180205 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4748306 180205 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585686 180359 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4750288 180359 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
147641221 180402 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
CHEMBL4750914 180402 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
153585718 180447 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 180447 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585581 180468 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751501 180468 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585708 180563 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4752808 180563 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)cc1 nan
153585648 180623 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 366 4 1 5 2.3 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4753388 180623 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 366 4 1 5 2.3 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162653764 180639 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2cc(C3CC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4753640 180639 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2cc(C3CC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585540 180714 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754565 180714 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585467 180715 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4754576 180715 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
152015494 180729 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2c(C3CC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4754735 180729 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2c(C3CC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
150352344 180877 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756243 180877 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(Cl)c(F)c1 nan
162655689 180889 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4756356 180889 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
153585712 180897 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756431 180897 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585415 180994 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180994 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
153585630 181101 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 346 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1F nan
CHEMBL4758841 181101 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 346 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1F nan
153585534 181190 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 181190 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
153585651 181308 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 382 4 1 5 2.8 C[C@H](NC(=O)Cn1nc2cc(Cl)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761154 181308 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 382 4 1 5 2.8 C[C@H](NC(=O)Cn1nc2cc(Cl)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585591 181382 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
CHEMBL4762126 181382 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
162659465 181426 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4762651 181426 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585610 181551 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 181551 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
153585689 181612 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2c1 nan
CHEMBL4764967 181612 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2c1 nan
162661302 181623 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4765018 181623 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585427 182087 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(C)cn3c2=O)cc1 nan
CHEMBL4780358 182087 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(C)cn3c2=O)cc1 nan
153585638 182306 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4782901 182306 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
153585409 182577 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4786542 182577 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
147410414 182787 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4789252 182787 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
153585385 182923 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
CHEMBL4790949 182923 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
162671538 182935 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 417 4 1 6 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)(F)F)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4791193 182935 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 417 4 1 6 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)(F)F)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162671011 183050 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 183050 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
148156995 183061 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4792896 183061 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151533016 183076 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 339 5 2 6 1.7 CNc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
CHEMBL4793093 183076 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 339 5 2 6 1.7 CNc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
153585429 183518 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
CHEMBL4798385 183518 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
153585699 183607 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.5 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4799647 183607 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.5 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585528 183670 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
CHEMBL4800338 183670 None 0 Human Binding pEC50 = 9 9.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
162644596 179525 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179525 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
153585418 179553 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4740519 179553 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585684 179639 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 4 1 6 2.2 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4741467 179639 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 4 1 6 2.2 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
152956498 179816 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
CHEMBL4743938 179816 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
153585688 179864 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4744340 179864 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162648790 179893 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4744737 179893 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
153585420 179916 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4744927 179916 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
162647825 179941 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179941 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
152005060 179968 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4745432 179968 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
150995037 180025 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4746108 180025 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585512 180134 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747431 180134 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162650006 180231 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
CHEMBL4748681 180231 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
151976938 180346 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 180346 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
153585686 180359 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4750288 180359 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
147634500 180384 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 180384 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
147641221 180402 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
CHEMBL4750914 180402 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
153585718 180447 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 180447 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585721 180457 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2ncc(Cl)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751414 180457 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2ncc(Cl)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585581 180468 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751501 180468 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585514 180479 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
CHEMBL4751629 180479 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
153585541 180487 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
CHEMBL4751720 180487 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
162653366 180566 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4752829 180566 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
153585655 180582 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
CHEMBL4752993 180582 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
153585421 180627 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 7 2.4 CC1COCCN1c1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4753419 180627 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 7 2.4 CC1COCCN1c1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
147378727 180633 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4753547 180633 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
162653797 180636 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 180636 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
148512747 180663 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1nccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4753915 180663 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1nccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
149101043 180709 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754476 180709 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585478 180711 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754503 180711 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585540 180714 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754565 180714 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585445 180863 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4756137 180863 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
94095050 180917 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4756787 180917 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657043 180928 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 379 5 1 7 1.6 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
CHEMBL4756879 180928 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 379 5 1 7 1.6 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
162656575 180989 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4757480 180989 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
162656504 181002 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4757619 181002 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
152460205 181040 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 451 6 2 8 1.5 C[C@H](NC(=O)Cn1nc2cccc(N3CC(O)C3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758096 181040 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 451 6 2 8 1.5 C[C@H](NC(=O)Cn1nc2cccc(N3CC(O)C3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585448 181056 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
CHEMBL4758322 181056 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
149421402 181062 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758375 181062 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657688 181161 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
CHEMBL4759611 181161 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
162657416 181226 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4760528 181226 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
150924716 181272 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
CHEMBL4760914 181272 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
153585574 181327 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 181327 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
162660420 181381 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4762121 181381 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585591 181382 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
CHEMBL4762126 181382 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
147987797 181390 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 181390 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
147323186 181490 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
CHEMBL4763362 181490 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
153585610 181551 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 181551 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
162661581 181570 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 181570 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
152494840 181603 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764839 181603 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162661302 181623 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4765018 181623 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585547 181847 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4777214 181847 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162644369 181936 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
CHEMBL4778327 181936 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
162665057 182172 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 182172 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
150561998 182237 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 475 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4782195 182237 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 475 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
149618414 182367 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
CHEMBL4783739 182367 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
153585463 182513 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCOCC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4785639 182513 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCOCC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
153585417 182533 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
CHEMBL4785963 182533 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
153585609 182578 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4786573 182578 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151394869 182642 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4787308 182642 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585701 182659 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 463 6 1 7 3.3 C[C@H](NC(=O)Cn1nc2cccc(N3CCCCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4787547 182659 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 463 6 1 7 3.3 C[C@H](NC(=O)Cn1nc2cccc(N3CCCCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151043804 182781 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182781 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162670176 182857 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4790080 182857 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585385 182923 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
CHEMBL4790949 182923 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
153585679 183029 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 183029 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162671011 183050 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 183050 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
148156995 183061 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4792896 183061 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585524 183236 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
CHEMBL4795078 183236 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
153585504 183317 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4795956 183317 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585386 183339 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 183339 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585438 183466 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
CHEMBL4797724 183466 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
153585532 183498 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 183498 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
153585429 183518 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
CHEMBL4798385 183518 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
153585528 183670 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
CHEMBL4800338 183670 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
153585707 183684 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4800487 183684 None 0 Rat Binding pEC50 = 9 9.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
162644596 179525 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179525 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648790 179893 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4744737 179893 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
162647825 179941 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179941 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
162649809 180151 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 180151 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
151976938 180346 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 180346 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
147634500 180384 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 180384 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
149094095 180388 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4750718 180388 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162653366 180566 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4752829 180566 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
162653797 180636 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 180636 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
152007746 180672 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
CHEMBL4754043 180672 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
153585713 181077 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1 nan
CHEMBL4758561 181077 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1 nan
153585574 181327 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 181327 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
147987797 181390 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 181390 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
162661581 181570 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 181570 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
153585547 181847 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4777214 181847 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162644369 181936 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
CHEMBL4778327 181936 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
162665057 182172 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 182172 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
151043804 182781 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182781 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585679 183029 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 183029 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162670606 183044 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
CHEMBL4792682 183044 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
153585386 183339 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 183339 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585532 183498 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 183498 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
147477854 183604 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2c(N3CCOCC3)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4799618 183604 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2c(N3CCOCC3)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
162644596 179525 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 179525 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648528 179920 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
CHEMBL4744984 179920 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
146976458 180136 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 507 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4747440 180136 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 507 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162649809 180151 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 180151 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
152844759 180205 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4748306 180205 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585550 180499 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4751886 180499 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
152007746 180672 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
CHEMBL4754043 180672 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
153585588 180892 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756392 180892 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585575 180935 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756937 180935 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585415 180994 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180994 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
153585534 181190 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 181190 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
153585663 181261 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
CHEMBL4760812 181261 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
153585643 181447 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4762957 181447 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181875 None 1 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181875 None 1 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
153585542 182412 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4784153 182412 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
162667558 182568 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4786371 182568 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
147410414 182787 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4789252 182787 None 0 Rat Binding pEC50 = 8 8.0 - 0
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
121349671 181859 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4777495 181859 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349806 183480 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4797857 183480 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349656 183595 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4799483 183595 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
121349756 182673 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4787761 182673 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
27785340 183577 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4799237 183577 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
27785340 183577 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4799237 183577 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
121349782 183150 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4794046 183150 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
164619649 185872 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
CHEMBL4866435 185872 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
26810968 186389 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
CHEMBL4874147 186389 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
11685 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
121349608 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
CHEMBL4779773 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
11685 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349608 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
CHEMBL4779773 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349786 182359 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4783626 182359 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349639 182523 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4785741 182523 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349786 182359 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
CHEMBL4783626 182359 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
121349639 182523 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4785741 182523 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
2695546 186222 None 9 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871792 186222 None 9 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349600 182691 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4788013 182691 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
121349548 183535 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798667 183535 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349548 183535 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798667 183535 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349554 183645 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
CHEMBL4800089 183645 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
36428174 182048 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4779855 182048 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
36428174 182048 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4779855 182048 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349659 182371 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4783774 182371 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349593 182979 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4791792 182979 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349593 182979 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
CHEMBL4791792 182979 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
121349633 182823 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4789631 182823 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
121349633 182823 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4789631 182823 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
2714527 185511 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4861019 185511 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
2714528 182584 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
CHEMBL4786641 182584 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
27838947 185537 None 1 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4861445 185537 None 1 Human Binding pKi = 5.8 5.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
121349658 182809 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4789475 182809 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
121349658 182809 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
CHEMBL4789475 182809 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
121349597 181917 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
CHEMBL4778124 181917 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
121349631 182588 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4786722 182588 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349631 182588 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4786722 182588 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349615 183231 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4795005 183231 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349564 181870 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4777630 181870 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349564 181870 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4777630 181870 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349588 182342 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783365 182342 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349572 181952 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4778561 181952 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349572 181952 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4778561 181952 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349778 182462 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4784744 182462 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
164617980 185135 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
CHEMBL4855076 185135 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
121349738 182203 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4781754 182203 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349559 181942 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
CHEMBL4778354 181942 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
164628435 186396 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4874254 186396 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
8036946 183545 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798779 183545 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
8036946 183545 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4798779 183545 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
121349701 182050 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
CHEMBL4779884 182050 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
121349710 183054 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4792828 183054 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349675 182071 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4780038 182071 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349683 182829 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4789720 182829 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
121349753 183000 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4792136 183000 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
121349753 183000 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
CHEMBL4792136 183000 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
78596259 185481 None 1 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4860510 185481 None 1 Human Binding pKi = 5.6 5.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349739 182276 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4782619 182276 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
2496250 28960 None 4 Human Binding pKi = 5.5 5.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1380104 28960 None 4 Human Binding pKi = 5.5 5.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349685 182239 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4782204 182239 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349685 182239 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4782204 182239 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
121349719 183365 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4796493 183365 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
121349787 182778 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4789079 182778 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349623 182206 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
CHEMBL4781805 182206 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
121349755 181909 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4778062 181909 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349773 182534 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
CHEMBL4785980 182534 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
121349614 181771 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
CHEMBL4776329 181771 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
121349720 182349 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
CHEMBL4783544 182349 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
121349645 181824 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4776988 181824 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
164611430 185330 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
CHEMBL4857947 185330 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
121349746 183490 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797979 183490 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349746 183490 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4797979 183490 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349745 182318 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4783071 182318 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
121349745 182318 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
CHEMBL4783071 182318 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
8036887 184846 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4850747 184846 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349781 181954 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4778563 181954 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349596 183547 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798863 183547 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349596 183547 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798863 183547 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349728 181922 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4778172 181922 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349728 181922 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
CHEMBL4778172 181922 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
121349688 183004 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4792174 183004 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
27783537 181789 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4776509 181789 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
121349587 182518 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4785669 182518 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349769 183033 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4792561 183033 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349689 183325 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4796061 183325 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349780 186475 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4875522 186475 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349628 182131 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4780801 182131 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
121349628 182131 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
CHEMBL4780801 182131 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
121349805 183226 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
CHEMBL4794908 183226 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
27754276 186037 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869182 186037 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
121349734 182202 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4781729 182202 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
121349734 182202 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
CHEMBL4781729 182202 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
121349574 182925 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4790968 182925 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349574 182925 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4790968 182925 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
121349569 182021 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4779481 182021 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
164609046 184591 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847108 184591 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349561 182836 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4789791 182836 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349719 183365 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4796493 183365 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349711 182973 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(F)c1 nan
CHEMBL4791752 182973 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(F)c1 nan
121349694 182321 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
CHEMBL4783106 182321 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
121349694 182321 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
CHEMBL4783106 182321 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
121349679 186374 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4873905 186374 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349566 182758 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4788831 182758 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
164621186 186200 None 0 Human Binding pKi = 5.1 5.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871591 186200 None 0 Human Binding pKi = 5.1 5.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349767 183436 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797410 183436 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349767 183436 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
CHEMBL4797410 183436 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
164620725 186191 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871506 186191 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349809 183267 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4795372 183267 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349740 182197 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4781651 182197 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349795 183555 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4798933 183555 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349558 182078 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4780121 182078 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
41757362 182319 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4783081 182319 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
41757362 182319 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4783081 182319 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
2144 2356 None 0 Human Binding pKi = 3.1 3.1 - 1
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
3313 2356 None 0 Human Binding pKi = 3.1 3.1 - 1
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6140 2356 None 0 Human Binding pKi = 3.1 3.1 - 1
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6925665 2356 None 0 Human Binding pKi = 3.1 3.1 - 1
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
CHEMBL301523 2356 None 0 Human Binding pKi = 3.1 3.1 - 1
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
DB00120 2356 None 0 Human Binding pKi = 3.1 3.1 - 1
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
2780 2373 None 60 Human Binding pKi = 3.1 3.1 -630 2
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6305 2373 None 60 Human Binding pKi = 3.1 3.1 -630 2
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6923516 2373 None 60 Human Binding pKi = 3.1 3.1 -630 2
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
717 2373 None 60 Human Binding pKi = 3.1 3.1 -630 2
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
CHEMBL54976 2373 None 60 Human Binding pKi = 3.1 3.1 -630 2
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
DB00150 2373 None 60 Human Binding pKi = 3.1 3.1 -630 2
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
11685 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
121349608 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
CHEMBL4779773 4139 None 28 Human Binding pKi = 6.9 6.9 - 1
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
2548547 2149 None 39 Human Binding pKi = 7.6 7.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500
8766 2149 None 39 Human Binding pKi = 7.6 7.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500
CHEMBL3633720 2149 None 39 Human Binding pKi = 7.6 7.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500